NOX1 and metabolic dysfunction-associated steatotic liver disease: A recent report also showed upregulation of NOX1 in non-alcoholic fatty liver disease (NAFLD), which impaired the hepatic microcirculation through formation of protein nitrotyrosine adducts and by reducing NO availability [151].